Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Double-Masked, Active-Controlled Study of the Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Ophthalmic Solution Administered With a Microdose Dispenser for Dilation of the Pupil

Trial Profile

A Double-Masked, Active-Controlled Study of the Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Ophthalmic Solution Administered With a Microdose Dispenser for Dilation of the Pupil

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Feb 2019

At a glance

  • Drugs Phenylephrine/tropicamide (Primary) ; Phenylephrine; Tropicamide
  • Indications Mydriasis
  • Focus Diagnostic use; Registrational
  • Acronyms MIST-1
  • Sponsors Eyenovia
  • Most Recent Events

    • 30 Jan 2019 According to an Eyenovia media release, the company expects to present the detailed results from the trial in a forthcoming scientific forum.
    • 30 Jan 2019 According to an Eyenovia media release, Dr. David Wirta, MD, is the principal investigator of the study.
    • 30 Jan 2019 Results presented in an Eyenovia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top